Pharmaceutical

New 2023 guidelines for the management of cardiomyopathies

A new set of European Society of Cardiology (ESC) guidelines was shared at the 2023 ESC conference in Amsterdam, Netherlands.

Sep 5, 2023 - 20:00
New 2023 guidelines for the management of cardiomyopathies
A new set of European Society of Cardiology (ESC) guidelines was shared at the 2023 ESC conference in Amsterdam, Netherlands.
Read the original article

Tags:

Previous Article

Launching pharmaceuticals in the Nordics: Opportunities and challenges

Next Article

VTE risk elevated in Swedish patients hospitalised for Covid-19

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Boston Scientific acquires urology company Axonics for $3.7 billion

STAT+: Boston Scientific acquires urology company Axoni...

Jan 8, 2024

TNT-119 by Eliem Therapeutics for Membranous Glomerulonephritis: Likelihood of Approval

TNT-119 by Eliem Therapeutics for Membranous Glomerulon...

May 19, 2024

UK MHRA strengthens regulations on fluoroquinolone antibiotics

UK MHRA strengthens regulations on fluoroquinolone anti...

Jan 23, 2024